• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 感染是导致 6 分钟步行试验距离缩短的独立危险因素。

HIV infection is an independent risk factor for decreased 6-minute walk test distance.

机构信息

Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.

Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, Washington, United States of America.

出版信息

PLoS One. 2019 Apr 24;14(4):e0212975. doi: 10.1371/journal.pone.0212975. eCollection 2019.

DOI:10.1371/journal.pone.0212975
PMID:31017909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6481785/
Abstract

BACKGROUND

Ambulatory function predicts morbidity and mortality and may be influenced by cardiopulmonary dysfunction. Persons living with HIV (PLWH) suffer from a high prevalence of cardiac and pulmonary comorbidities that may contribute to higher risk of ambulatory dysfunction as measured by 6-minute walk test distance (6-MWD). We investigated the effect of HIV on 6-MWD.

METHODS

PLWH and HIV-uninfected individuals were enrolled from 2 clinical centers and completed a 6-MWD, spirometry, diffusing capacity for carbon monoxide (DLCO) and St. George's Respiratory Questionnaire (SGRQ). Results of 6-MWD were compared between PLWH and uninfected individuals after adjusting for confounders. Multivariable linear regression analysis was used to determine predictors of 6-MWD.

RESULTS

Mean 6-MWD in PLWH was 431 meters versus 462 in 130 HIV-uninfected individuals (p = 0.0001). Older age, lower forced expiratory volume (FEV1)% or lower forced vital capacity (FVC)%, and smoking were significant predictors of decreased 6-MWD in PLWH, but not HIV-uninfected individuals. Lower DLCO% and higher SGRQ were associated with lower 6-MWD in both groups. In a combined model, HIV status remained an independent predictor of decreased 6-MWD (Mean difference = -19.9 meters, p = 0.005).

CONCLUSIONS

HIV infection was associated with decreased ambulatory function. Airflow limitation and impaired diffusion capacity can partially explain this effect. Subjective assessments of respiratory symptoms may identify individuals at risk for impaired physical function who may benefit from early intervention.

摘要

背景

门诊功能可预测发病率和死亡率,可能受心肺功能障碍的影响。 艾滋病毒感染者(PLWH)患有高比例的心脏和肺部合并症,这可能导致 6 分钟步行试验距离(6-MWD)测量的活动障碍风险更高。 我们研究了 HIV 对 6-MWD 的影响。

方法

从 2 个临床中心招募 PLWH 和未感染 HIV 的个体,并完成 6-MWD、肺量测定、一氧化碳弥散量(DLCO)和圣乔治呼吸问卷(SGRQ)。 在调整混杂因素后,比较 PLWH 和未感染个体的 6-MWD 结果。 多变量线性回归分析用于确定 6-MWD 的预测因素。

结果

PLWH 的平均 6-MWD 为 431 米,而 130 名未感染 HIV 的个体为 462 米(p = 0.0001)。 年龄较大、较低的用力呼气量(FEV1)%或较低的用力肺活量(FVC)%,以及吸烟是 PLWH 6-MWD 下降的显著预测因素,但不是未感染 HIV 的个体。 较低的 DLCO%和较高的 SGRQ 与两组个体的较低 6-MWD 相关。 在综合模型中,HIV 状态仍然是 6-MWD 降低的独立预测因素(平均差异=-19.9 米,p = 0.005)。

结论

HIV 感染与活动能力下降相关。 气流受限和弥散能力受损可能部分解释这种影响。 呼吸症状的主观评估可能会识别出有活动障碍风险的个体,这些个体可能受益于早期干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ded3/6481785/20b5ed881222/pone.0212975.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ded3/6481785/20b5ed881222/pone.0212975.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ded3/6481785/20b5ed881222/pone.0212975.g001.jpg

相似文献

1
HIV infection is an independent risk factor for decreased 6-minute walk test distance.HIV 感染是导致 6 分钟步行试验距离缩短的独立危险因素。
PLoS One. 2019 Apr 24;14(4):e0212975. doi: 10.1371/journal.pone.0212975. eCollection 2019.
2
HIV infection is associated with reduced pulmonary diffusing capacity.HIV 感染与肺弥散能力降低有关。
J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):271-8. doi: 10.1097/QAI.0b013e3182a9215a.
3
Diagnostic performance of clinical characteristics to detect airflow limitation in people living with HIV and in uninfected controls.用于诊断 HIV 感染者和未感染者气流受限的临床特征的诊断性能。
HIV Med. 2018 Nov;19(10):751-755. doi: 10.1111/hiv.12669. Epub 2018 Aug 30.
4
Reduced Forced Vital Capacity Among Human Immunodeficiency Virus-Infected Middle-Aged Individuals.人类免疫缺陷病毒感染的中年个体的用力肺活量降低。
J Infect Dis. 2019 Apr 8;219(8):1274-1284. doi: 10.1093/infdis/jiy653.
5
On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI.在无气流受限的戒烟者中,异常 DL(CO) 的作用:症状、运动能力和超极化氦-3 MRI。
Thorax. 2013 Aug;68(8):752-9. doi: 10.1136/thoraxjnl-2012-203108. Epub 2013 Apr 19.
6
Pulmonary Function and Quality of Life in Aging Men With and Without HIV from the Multicenter AIDS Cohort Study.衰老男性中有无 HIV 的人群的肺功能和生活质量:来自多中心艾滋病队列研究。
AIDS Res Hum Retroviruses. 2023 Dec;39(12):621-632. doi: 10.1089/AID.2023.0001. Epub 2023 Jun 28.
7
Diffusing Capacity of Carbon Monoxide in Assessment of COPD.一氧化碳弥散量在 COPD 评估中的应用。
Chest. 2019 Dec;156(6):1111-1119. doi: 10.1016/j.chest.2019.06.035. Epub 2019 Jul 25.
8
Association Between CD4, Viral Load, and Pulmonary Function in HIV.HIV患者中CD4、病毒载量与肺功能之间的关联
Lung. 2017 Oct;195(5):635-642. doi: 10.1007/s00408-017-0030-5. Epub 2017 Jun 24.
9
Pulmonary Function Trajectories in People with HIV: Analysis of the Pittsburgh HIV Lung Cohort.HIV 感染者的肺功能轨迹:匹兹堡 HIV 肺队列分析。
Ann Am Thorac Soc. 2022 Dec;19(12):2013-2020. doi: 10.1513/AnnalsATS.202204-332OC.
10
[Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].[采用层次聚类分析和两步聚类分析对症状性慢性气道疾病临床表型的研究]
Zhonghua Nei Ke Za Zhi. 2016 Sep 1;55(9):679-83. doi: 10.3760/cma.j.issn.0578-1426.2016.09.005.

引用本文的文献

1
No evidence of pitavastatin effect on muscle area or density among people with HIV.没有证据表明匹伐他汀对艾滋病毒感染者的肌肉面积或密度有影响。
AIDS. 2025 Jul 22. doi: 10.1097/QAD.0000000000004306.
2
Chronic Obstructive Pulmonary Disease in People with HIV: an Evidence-Based Review.HIV感染者中的慢性阻塞性肺疾病:一项基于证据的综述。
HIV AIDS (Auckl). 2025 Jun 12;17:153-174. doi: 10.2147/HIV.S496211. eCollection 2025.
3
Effect of HIV on respiratory symptoms, health status, and exertional capacity.人类免疫缺陷病毒对呼吸道症状、健康状况及运动能力的影响。

本文引用的文献

1
Atypical Skeletal Muscle Profiles in Human Immunodeficiency Virus-Infected Asymptomatic Middle-Aged Adults.人类免疫缺陷病毒感染无症状中年成年人的非典型骨骼肌特征。
Clin Infect Dis. 2018 Jun 1;66(12):1918-1927. doi: 10.1093/cid/cix1121.
2
Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.抗反转录病毒治疗时代的 HIV 感染成人肺部疾病。
AIDS. 2018 Jan 28;32(3):277-292. doi: 10.1097/QAD.0000000000001712.
3
Diminished physical function in older HIV-infected adults in the Southeastern U.S. despite successful antiretroviral therapy.
AIDS. 2025 Jul 15;39(9):1235-1245. doi: 10.1097/QAD.0000000000004179. Epub 2025 Mar 12.
4
Determinants and reference values of the 6-min walk distance in the general population-results of the population-based STAAB cohort study.一般人群中6分钟步行距离的决定因素和参考值——基于人群的STAAB队列研究结果
Clin Res Cardiol. 2024 Jan 18. doi: 10.1007/s00392-023-02373-3.
5
COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies.HIV 感染者中的 COPD:流行病学、发病机制、管理和预防策略。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 29;18:2795-2817. doi: 10.2147/COPD.S388142. eCollection 2023.
6
Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID With Exercise Capacity and Chronotropic Incompetence Among People With HIV.严重急性呼吸综合征冠状病毒 2 感染和心肺长新冠与艾滋病毒感染者运动能力和变时性功能不全的关联。
J Am Heart Assoc. 2023 Oct 17;12(20):e030896. doi: 10.1161/JAHA.123.030896. Epub 2023 Oct 13.
7
HIV-associated lung disease.HIV 相关肺部疾病。
Nat Rev Dis Primers. 2023 Jul 27;9(1):39. doi: 10.1038/s41572-023-00450-5.
8
Isolated abnormal diffusing capacity for carbon monoxide (iso↓DLco) is associated with increased respiratory symptom burden in people with HIV infection.孤立性一氧化碳弥散量降低与 HIV 感染者呼吸症状负担增加相关。
PLoS One. 2023 Jul 18;18(7):e0288803. doi: 10.1371/journal.pone.0288803. eCollection 2023.
9
Pulmonary Function Trajectories in People with HIV: Analysis of the Pittsburgh HIV Lung Cohort.HIV 感染者的肺功能轨迹:匹兹堡 HIV 肺队列分析。
Ann Am Thorac Soc. 2022 Dec;19(12):2013-2020. doi: 10.1513/AnnalsATS.202204-332OC.
10
Chronic obstructive pulmonary disease in HIV.HIV 相关慢性阻塞性肺疾病。
Expert Rev Respir Med. 2021 Jan;15(1):71-87. doi: 10.1080/17476348.2021.1848556. Epub 2020 Nov 23.
美国东南部老年HIV感染者尽管抗逆转录病毒治疗成功,但身体功能仍有所下降。
PLoS One. 2017 Jun 29;12(6):e0179874. doi: 10.1371/journal.pone.0179874. eCollection 2017.
4
Prediction of Poor Short-Term Prognosis and Unmet Needs in Advanced Chronic Obstructive Pulmonary Disease: Use of the Two-Minute Walking Distance Extracted from a Six-Minute Walk Test.晚期慢性阻塞性肺疾病短期预后不良及未满足需求的预测:利用六分钟步行试验中提取的两分钟步行距离
J Palliat Med. 2017 Aug;20(8):821-828. doi: 10.1089/jpm.2016.0449. Epub 2017 Mar 29.
5
Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.在英国,病毒学抑制的HIV感染阳性成年患者的呼吸健康状况受损。
HIV Med. 2017 Sep;18(8):604-612. doi: 10.1111/hiv.12497. Epub 2017 Mar 13.
6
The effects of chronic obstructive pulmonary disease self-management interventions on improvement of quality of life in COPD patients: A meta-analysis.慢性阻塞性肺疾病自我管理干预对慢性阻塞性肺疾病患者生活质量改善的影响:一项荟萃分析。
Respir Med. 2016 Dec;121:81-90. doi: 10.1016/j.rmed.2016.11.005. Epub 2016 Nov 3.
7
The Differential Impact of Emphysema on Respiratory Symptoms and 6-Minute Walk Distance in HIV Infection.肺气肿对HIV感染患者呼吸症状和6分钟步行距离的差异影响。
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):e23-e29. doi: 10.1097/QAI.0000000000001133.
8
Epidemiology of HIV-Associated Lung Disease in the United States.美国HIV相关肺部疾病的流行病学
Semin Respir Crit Care Med. 2016 Apr;37(2):181-98. doi: 10.1055/s-0036-1572556. Epub 2016 Mar 14.
9
Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients.HIV感染和未感染患者中与慢性阻塞性肺疾病急性加重相关的危险因素。
AIDS. 2016 Jan 28;30(3):455-63. doi: 10.1097/QAD.0000000000000940.
10
Impact of HIV infection and smoking on lung immunity and related disorders.HIV 感染和吸烟对肺部免疫及相关疾病的影响。
Eur Respir J. 2015 Dec;46(6):1781-95. doi: 10.1183/13993003.00353-2015. Epub 2015 Aug 6.